what does chemicals pharmaceuticals do

IOL Chemicals and Pharmaceuticals Limited (IOLCP) operates in the pharmaceutical and specialty chemicals sectors, manufacturing and selling products for both domestic and international markets, with a strong focus on APIs and specialty chemicals.

what products does chemicals pharmaceuticals make

The company produces a range of pharmaceutical active ingredients (APIs), specialty chemicals, and related products, including significant manufacturing of Ibuprofen, making it a global leader in that specific product.

IOLCP engages in the manufacturing and sale of pharmaceutical and chemical products, operating through two main segments: Chemical and Pharmaceutical, serving both Indian and global markets with a diversified product portfolio.

what is the future of iolcp share

The future of IOLCP shares depends on factors like its performance in APIs and specialty chemicals, global demand trends, and financial metrics such as its current market cap and PE ratio, which indicate moderate investor sentiment.

what sector is chemicals pharmaceuticals in

IOL Chemicals and Pharmaceuticals Limited operates in the pharmaceuticals and specialty chemicals sector, focusing on manufacturing and supplying APIs, chemicals, and related products for both domestic and export markets.

IOLCP

BSE

IOL Chemicals and Pharmaceuticals Limited

Healthcare· Pharmaceuticals & Biotechnology· INE485C01029· Scrip: 524164

EN हिन्दी ગુજરાતી मराठी

₹१२९.४५

▲ 3.45 (+0.00%)

2026-06-10

BSE

₹१२९.४५

▲ ३.४५

+०.००%

२२८ कारोबारी दिन · 1Y अवधि

आज (BSE)

खुलना१३३.००

उच्च१३६.५०

निम्न१२९.०५

पिछला बंद१३२.९०

मात्रा१.०७L

मूल्य₹१.४Cr

L: 129.05H: 136.50

जानकारी

अंकित मूल्य₹२

सूचीबद्ध2010-11-08

ISININE485C01029

SeriesB

BSE स्क्रिप524164

मुख्य संकेतक

1D

—

1W

—

1M

—

3M

—

6M

—

मूल्यांकन

P/E (TTM)—

P/E (Qtr Ann.)—

P/Sales—

बाज़ार पूंजी—

वृद्धि (तिमाही)

राजस्व-0.47%

PAT+7.21%

EPS+7.36%

लाभप्रदता

EBITDA मार्जिन११.१%

शुद्ध मार्जिन३.९%

TTM EBITDA M.११.५%

TTM शुद्ध M.४.७%

लाभांश

यील्ड—

नवीनतम DPS₹१

भुगतान अनुपात१४२.९%

वृद्धि-75.00%

TTM राजस्व

₹2055 Cr

TTM EBITDA

₹236 Cr

TTM PAT

₹97 Cr

TTM EPS

₹३.३१

प्रति शेयर राजस्व

₹७०.०

त्रैमासिक वित्तीय

राजस्व

EBITDA

PAT

EPS

तिमाही	राजस्व	Expenses	EBITDA	PBT	PAT	EPS
2024-12-31	523 Cr	500 Cr	58 Cr	28 Cr	21 Cr	₹0.70
2024-09-30	526 Cr	506 Cr	55 Cr	26 Cr	19 Cr	₹0.65
2024-06-30	502 Cr	471 Cr	56 Cr	39 Cr	30 Cr	₹1.01
2024-03-31	504 Cr	474 Cr	67 Cr	37 Cr	28 Cr	₹0.94
2023-12-31	520 Cr	497 Cr	62 Cr	32 Cr	23 Cr	₹0.79
2023-09-30	545 Cr	501 Cr	85 Cr	51 Cr	38 Cr	₹1.29
2023-03-31	587 Cr	509 Cr	126 Cr	87 Cr	65 Cr	₹2.21
2022-12-31	523 Cr	497 Cr	58 Cr	33 Cr	24 Cr	₹0.81

शेयरधारिता पैटर्न

वर्तमान — 2026-03-31

प्रमोटर57.5%

FII1.7%

DII0.0%

सार्वजनिक42.5%

प्रमोटर होल्डिंग ट्रेंड

कॉर्पोरेट कार्यवाही

एक्स-तारीख	प्रकार	उद्देश्य
2026-02-17	Dividend	Interim Dividend - Re 1 Per Share
2025-03-11	Split	Face Value Split (Sub-Division) - From Rs 10/- Per Share To Rs 2/- Per Share
2025-02-18	Dividend	Interim Dividend - Rs 4 Per Share
2024-08-16	Other	Annual General Meeting
2024-02-16	Dividend	Interim Dividend - Rs 5 Per Share
2023-08-03	Other	Annual General Meeting
2023-02-17	Dividend	Interim Dividend - Rs 4 Per Share
2022-08-18	Other	Annual General Meeting
2022-02-15	Dividend	Interim Dividend - Rs 4 Per Share
2021-09-08	Dividend	Annual General Meeting/Dividend - Rs 2 Per Share
2020-11-17	Dividend	Interim Dividend - Rs 4 Per Share
2020-09-17	Other	Annual General Meeting
2020-03-18	Dividend	Interim Dividend - Rs 3 Per Share
2019-08-21	Other	Annual General Meeting
2018-09-19	Other	Annual General Meeting
2017-09-19	Other	Annual General Meeting
2016-09-19	Other	Annual General Meeting
2015-09-18	Other	Annual General Meeting
2014-09-19	Other	Annual General Meeting
2013-09-20	Other	Annual General Meeting

आय विवरण

IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Investor Presentation

21 May 2026NSE28K chars

Read →

IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Investor Presentation

12 Nov 2025NSE29K chars

Read →

IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Investor Presentation

7 Aug 2025NSE26K chars

Read →

IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Investor Presentation

19 May 2025NSE28K chars

Read →

IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Investor Presentation

13 Feb 2025NSE27K chars

Read →

IOL Chemicals and Pharmaceuticals Limited has informed the Exchange about Investor Presentation

9 Nov 2023NSE26K chars

Read →

मूल्य इतिहास

तारीख	खुलना	उच्च	निम्न	बंद	मात्रा
2026-06-10	१३३.५०	१३६.५०	१२८.७५	१२९.५४	२०.७९L
2026-06-03	१३०.९०	१३४.२९	१२८.६५	१३०.९७	१७.७२L
2026-05-27	१३६.६५	१३७.५९	१३०.००	१३१.४०	४५.५१L
2026-05-26	१२४.९५	१३८.९०	१२४.९४	१३६.०६	१.९१Cr
2026-05-25	११९.२१	१२६.००	११९.२१	१२४.००	६४.०२L
2026-05-22	१२१.०५	१२४.४०	११८.२१	११८.७३	५८.२९L
2026-05-21	११८.८१	१२६.७२	११४.४७	१२१.१७	१.७६Cr
2026-05-20	१०९.००	१२१.४०	१०७.०१	११९.५४	२.११Cr
2026-05-19	१०९.४५	१११.९५	१०८.०१	११०.१२	२४.०१L
2026-05-18	१०५.७०	१०९.७०	१०३.७६	१०८.४४	३०.०२L
2026-05-15	१०९.९०	१०९.९०	१०५.५०	१०५.९४	१६.१९L
2026-05-14	१०७.५०	११३.७०	१०६.३४	१०९.३५	४०.२२L
2026-05-13	१०६.७०	१०८.३८	१०४.१३	१०६.२२	३०.९९L
2026-05-12	१०९.७०	११६.४६	१०५.००	१०५.७१	१.२५Cr
2026-05-11	९७.२४	११३.४०	९६.५०	१०८.७७	१.९९Cr
2026-05-08	९८.३०	९९.२४	९६.२७	९६.८९	१०.३५L
2026-05-07	९६.५०	९९.९५	९६.१०	९७.८१	१९.६७L
2026-05-06	९५.३७	९७.५९	९४.८६	९६.०४	१४.३७L
2026-05-05	९५.००	९६.४०	९४.१०	९४.६३	५.७३L
2026-05-04	९५.००	९७.०५	९४.५५	९४.९९	७.९३L
2026-04-30	९४.८७	९६.८३	९३.४४	९४.३२	१३.८०L
2026-04-29	९१.००	९७.७९	९१.००	९५.६३	४८.०६L
2026-04-28	९२.००	९३.४०	९०.१०	९०.८५	७.६२L
2026-04-27	९०.००	९२.८०	९०.००	९२.२९	९.५८L
2026-04-24	९२.७०	९३.६०	८७.५०	८९.११	१४.६६L
2026-04-23	९३.८०	९५.५९	९२.१२	९२.५८	१५.२७L
2026-04-22	९१.२३	९५.००	९१.०३	९४.१३	२९.८२L
2026-04-21	८७.६४	९२.०९	८६.९२	९१.२३	१८.४२L
2026-04-20	९१.१०	९१.३०	८७.१०	८७.६५	१३.३२L
2026-04-17	८५.४७	९३.७३	८५.४५	९१.१३	५३.०२L

अक्सर पूछे जाने वाले प्रश्न

के बारे में

आईओएल केमिकल्स एंड फार्मास्यूटिकल्स लिमिटेड एक अग्रणी भारतीय कंपनी है जो फार्मास्यूटिकल्स और विशेष रसायनों के निर्माण और निर्यात में विशेषज्ञता रखती है, इबुप्रोफेन में एक महत्वपूर्ण वैश्विक बाजार हिस्सेदारी के साथ। कंपनी दुनिया भर में इबुप्रोफेन बाजार में 35% हिस्सेदारी के साथ सबसे बड़ी खिलाड़ी होने के लिए प्रसिद्ध है।

BOARD OF DIRECTORS

Vijay Garg

Managing Director

DEPARTED

Harpal Singh

Independent Director

Rajni Jha

Independent Director

Sandhya Mehta

Independent Director

Rajender Mohan Malla